Kolon TissueGene (950160)
KRX SM KOSDAQ Primary KRX SM Summary
950160 Chart
Kolon TissueGene (950160) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Kolon TissueGene ever had a stock split?
Kolon TissueGene Profile
| Capital Markets Industry | Financials Sector | Jane Elizabeth Trust CEO | KRX SM Exchange | KR8840120008 ISIN |
| US Country | 1,400 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Specializing in direct investment in American equities, this company targets a focused approach by concentrating on large and medium-sized companies within the Consumer Staples sector. With a portfolio that covers 85% of this essential sector, the firm offers sector-specific exposure to investors seeking to capitalize on the steady demand for consumer staples products. This strategic concentration in a sector known for its resilience to economic cycles aims to provide investors with consistent returns and reduced portfolio volatility.
Products and Services
- Direct Equity Investments
Providing direct investment opportunities in a meticulously selected range of large and medium-sized companies within the Consumer Staples sector. These investments aim to leverage the intrinsic stability and ongoing demand characteristic of this sector, focusing on long-term growth and capital preservation.
- Sector-Specific Exposure
Specialized sector-specific exposure to the Consumer Staples market, covering 85% of the sector. This service is designed for investors looking to concentrate their investments in the Consumer Staples sector, benefiting from the sector's relative safety and stability compared to more cyclical industries.
